Literature DB >> 18379296

Update of prostate magnetic resonance imaging at 3 T.

Chan Kyo Kim1, Byung Kwan Park.   

Abstract

More recently, 3-T magnetic resonance (MR) scanner become more clinically available, and clinical application of 3-T MR imaging (MRI) of the abdomen and pelvis is now feasible and being performed at many institutions. However, few prostrate 3-T MRI studies have been published. The increase in signal-to-noise ratio at 3 versus 1.5 T clearly improves spatiotemporal and spectral resolutions of the prostate. Thus, we asked whether 3-T MRI improves the localization and staging of prostate cancer versus 1.5-T MRI. To answer this question, this article reviews the current limitations of prostate 1.5-T MRI and addresses its pros and cons. Moreover, we present preliminary results of prostate 3-T MRI and introduce our experience for prostate 3-T MRI using a phased-array coil, with an emphasis on imaging sequences, for example, T2-weighted, dynamic contrast-enhanced, diffusion-weighted, and MR spectroscopic imaging.

Entities:  

Mesh:

Year:  2008        PMID: 18379296     DOI: 10.1097/RCT.0b013e3180683b99

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  17 in total

Review 1.  Diffusion weighted imaging in prostate cancer.

Authors:  Cher Heng Tan; Jihong Wang; Vikas Kundra
Journal:  Eur Radiol       Date:  2010-10-09       Impact factor: 5.315

2.  [The relevance of magnetic resonance imaging (MRI) for the detection and exclusion of prostate cancer].

Authors:  J Stattaus; M Forsting
Journal:  Urologe A       Date:  2010-03       Impact factor: 0.639

3.  Diffusion tensor imaging of normal prostate at 3 T: effect of number of diffusion-encoding directions on quantitation and image quality.

Authors:  C K Kim; S M Jang; B K Park
Journal:  Br J Radiol       Date:  2011-09-06       Impact factor: 3.039

4.  [Imaging diagnostics of the prostate].

Authors:  D J Dinter; A M Weidner; F Wenz; A E Pelzer; M S Michel; S O Schoenberg
Journal:  Urologe A       Date:  2010-08       Impact factor: 0.639

5.  Prostate magnetic resonance imaging at 3 Tesla: Is administration of hyoscine-N-butyl-bromide mandatory?

Authors:  Matthias C Roethke; Timur H Kuru; Alexander Radbruch; Boris Hadaschik; Heinz-Peter Schlemmer
Journal:  World J Radiol       Date:  2013-07-28

6.  Central gland and peripheral zone prostate tumors have significantly different quantitative imaging signatures on 3 Tesla endorectal, in vivo T2-weighted MR imagery.

Authors:  Satish E Viswanath; Nicholas B Bloch; Jonathan C Chappelow; Robert Toth; Neil M Rofsky; Elizabeth M Genega; Robert E Lenkinski; Anant Madabhushi
Journal:  J Magn Reson Imaging       Date:  2012-02-15       Impact factor: 4.813

7.  Modalities for imaging of prostate cancer.

Authors:  A H Hou; D Swanson; A B Barqawi
Journal:  Adv Urol       Date:  2010-03-17

Review 8.  [Rational imaging in locally advanced prostate cancer].

Authors:  M Beissert; R Lorenz; E W Gerharz
Journal:  Urologe A       Date:  2008-11       Impact factor: 0.639

9.  Novel PCA-VIP scheme for ranking MRI protocols and identifying computer-extracted MRI measurements associated with central gland and peripheral zone prostate tumors.

Authors:  Shoshana B Ginsburg; Satish E Viswanath; B Nicolas Bloch; Neil M Rofsky; Elizabeth M Genega; Robert E Lenkinski; Anant Madabhushi
Journal:  J Magn Reson Imaging       Date:  2014-06-18       Impact factor: 4.813

Review 10.  Multidisciplinary functional MR imaging for prostate cancer.

Authors:  Jeong Kon Kim; Yun-Jin Jang; Gyunggoo Cho
Journal:  Korean J Radiol       Date:  2009 Nov-Dec       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.